探索薬物動態におけるCaco-2細胞を用いた膜透過性試験―HTSと特性解析

DOI Web Site 参考文献17件
  • 嶋田 薫
    ファイザー製薬・中央研究所・薬物動態研究部

書誌事項

タイトル別名
  • MEMBRANE-PERMEABILITY ASSAY USING CACO-2 CELLS IN DRUG DISCOVERY

この論文をさがす

抄録

The Caco-2 human-epithelial cell line has been widely used as a tissue-culture model for permeability measurements to predict human oral absorption in the drug discovery stage. In my presentation I will address some of the strategic applications of the Caco-2 model. Physicochemical properties affect the permeability. For example, permeability tends to be underestimated in hydrophilic compounds. For determining the permeability of poorly soluble drugs, some solubilizing reagents or bovine serum albumin can be used. The expression of some carrier-mediated transport systems has been confirmed on Caco-2 cell monolayers; therefore, we should pay attention to evaluating compounds that may be substrates of the transporters. The pH of the medium also affects the result of this assay. Transport studies with an apical pH value at 6.0 or 6.5 showed better prediction of in vivo drug absorption in human. For compounds that are substrates of P-glycoprotein (Pgp), the use of a Pgp inhibitor resulted in a better estimate of absorption in humans. The results suggest that compounds can be ranked according to how well they are absorbed; namely, those with Papp less than 1×10-6cm/s (poorly absorbed), between 1×10-6cm/s and 1×10-5cm/s (moderately absorbed), and greater than 1×10-5cm/s (well absorbed). The data of the Caco-2 assays are sometimes different, however, from those in different laboratories due to fluctuations in permeability resulting from passages and culture conditions, even when using the same clone. For high throughput screening, the permeability in 96-well Caco-2 assay demonstrates a good correlation with known human absorption for a variety of compounds. This is comparable to a 24-well system. Automation machines can be successfully applied for Caco-2 assays. Several in silicostudies for the prediction of Caco-2 permeability have also been conducted. A database system to which scientists easily access should be developed in collaboration with information-technologyg roups.

収録刊行物

  • 薬物動態

    薬物動態 16 (supplement), 152-153, 2001

    日本薬物動態学会

参考文献 (17)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ